Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Jefferies Maintains Hold on Paychex, Lowers Price Target to $120

Jefferies Maintains Hold on Paychex, Lowers Price Target to $120

Jefferies analyst Samad Samana maintains Paychex (NASDAQ:PAYX) with a Hold and lowers the price target from $130 to $120.

byBenzinga Newsdesk

December 23, 2022

1 minute read

Jefferies analyst Samad Samana maintains Paychex (NASDAQ:PAYX) with a Hold and lowers the price target from $130 to $120.

Analyst Ratings

Expert Ratings for Health Catalyst

By Benzinga Insights

December 13, 4:00 PM

Within the last quarter, Health Catalyst (NASDAQ:HCAT) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

HCAT

News
Tech

Frontier Airlines in talks with SpaceX about Starlink

By Charles Gross

September 15, 4:59 PM

https://www.teslarati.com/frontier-airlines-spacex-starlink/

ULCC

Optimism’s Private Token Sale: A Boon For Treasury, Or A Sign Of Things To Come?

By Murtuza Merchant

September 21, 12:33 PM

The Optimism Foundation will conduct a private token sale, amounting to approximately 116 million (CRYPTO: OP) tokens. This move involves seven buyers and is primarily aimed at treasury management, the foundation said.

Analyst Ratings

Keybanc Maintains Overweight Rating for West Pharmaceutical Servs: Here’s What You Need To Know

By Benzinga Insights

February 13, 1:00 PM

Keybanc has decided to maintain its Overweight rating of West Pharmaceutical Servs (NYSE:WST) and raise its price target…

WST

Jefferies Maintains Hold on Paychex, Lowers Price Target to $120

Related Posts

Expert Ratings for Health Catalyst

Frontier Airlines in talks with SpaceX about Starlink

Optimism’s Private Token Sale: A Boon For Treasury, Or A Sign Of Things To Come?

Keybanc Maintains Overweight Rating for West Pharmaceutical Servs: Here’s What You Need To Know